Comment from Anonymous
AnonymousSupportIndividual
Summary: A registered nurse with over 40 years of experience supports the proposed action to move Hydroxychloroquine and Ivermectin to over-the-counter status. The commenter argues that both drugs are safe, have established medical uses, and were effective in treating early COVID-19 infections.
I am writing as an RN with 40+ years of experience to encourage the release of Hydroxychloroquine and Ivermectin to OTC status. Hydroxychloroquine (HCQ) has been FDA-approved for decades and is available OTC in many parts of the world, such as in Africa and South America, for the prevention and treatment of malaria. In the United States and other Western Nations, HCQ is a widely prescribed medication primarily used to treat rheumatoid arthritis and lupus. According to the government’s own database, FAERS (FDA Adverse Event Reporting System), HCQ is one of the safest drugs on the planet. Ivermectin is a wide-ranging antiparasitic agent that has been used in humans for over three decades and won the Nobel Prize in Medicine in 2015, reflecting the drug's enormous impact on human health. Considered extremely safe, ivermectin is FDA-approved to treat threadworm infection and river blindness, with millions of treatments administered in global public health campaigns. Although it is used to treat parasites, ivermectin has gained much attention for its potential use in cancer treatment. There is absolutely no dispute that both of these drugs are extremely safe.
In addition, the application of these medications for new purposes is ongoing and very successful. People who were able to access these medications early in a COVID infection experienced excellent results until the army of “Fauci busybodies” cut off access. This must never be allowed to happen again.